HAV and HBV seroprevalence in 1,000 patients with chronic HCV infection in a Tertiary Care Center in São Paulo, Brazil

by Edvaldo F. da Silva, Daniel F. Mazo, Claudia P. Oliveira, Roseane P. Medeiros, Flair J. Carrilho, Mário G. Pessôa
Published 2016-09-01

O-18 IMPAIRED ANTI-HBV VACCINE RESPONSE IN NON-CIRRHOTIC CHRONIC HCV PATIENTS IS NOT OVERCOME BY DOUBLE DOSE REGIMEN. FOURTH DOSE MAYBE THE ANSWER!

by Roseane Pôrto Medeiros, Norah A. Terrault, Daniel F. Mazo, Claudia P. Oliveira, Jennifer L. Dodge, Patricia M. Zitelli, M. Lopes, Flair J. Carrilho, Mário Guimarães Pessoa
Published 2021-09-01

EncephalApp Stroop Test validation for the screening of minimal hepatic encephalopathy in Brazil

by Marlone Cunha-Silva, Fernando L. Ponte Neto, Priscila S. de Araújo, Lucas V. Pazinato, Raquel D. Greca, Tirzah M.L. Secundo, Marcello R. Imbrizi, Leonardo T. Monici, Tiago Sevá-Pereira, Daniel F. Mazo
Published 2022-01-01

Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population

by Daniel F. Mazo, Fernanda M. Malta, Jose Tadeu Stefano, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Jazon R. Almeida, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira
Published 2019-05-01

P-5 HEPATITIS E VIRUS INFECTION INCREASES THE RISK OF DIABETES AND MORTALITY IN HCV infected patients

by Patricia Momoyo Yoshimura Zitelli, Michele Gomes-Gouvêa, Daniel F. Mazo, Julio da Motta Singer, Claudia PMS Oliveira, Alberto Queiroz Farias, João Renato Pinho, Ryan YukimatsuTanigawa, Venancio Avancini Ferreira Alves, Flair José Carrilho, Mário Guimarães Pessoa
Published 2021-09-01

The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C

by Arthur Ivan N. Oliveira, Fernanda M. Malta, Patricia Momoyo Y. Zitelli, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira, Maria Cássia Mendes-Corrêa, Mario G. Pessoa, Daniel F. Mazo
Published 2021-02-01

O-1 THE ROLE OF PNPLA3 AND TM6SF2 POLYMORPHISMS ON LIVER FIBROSIS AND METABOLIC ABNORMALITIES IN BRAZILIAN PATIENTS WITH CHRONIC HEPATITIS C

by Arthur Ivan N. Oliveira, Fernanda M. Malta, Patricia Momoyo Y. Zitelli, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira, Maria Cássia Mendes-Corrêa, Mario G. Pessoa, Daniel F. Mazo
Published 2021-09-01

O-10 PRIMARY BILIARY CHOLANGITIS PATIENTS DIAGNOSED BY DIFFERENT COMBINATIONS OF THE DIAGNOSTIC CRITERIA PRESENT CLINICAL AND LABORATORY PECULIARITIES

by Guilherme G.L. Cançado, Eduardo L.R. Cançado, Maria L.G. Ferraz, Cristiane A. Villela-Nogueira, Debora R.B. Terrabuio, Michelle H. Braga, Mateus J. Nardelli, Luciana C. Faria, Nathalia M.F. GOMES, ELZE M.G. Oliveira, Vivian Rotman, Maria Beatriz Oliveira, Simone M.C.F. Cunha, Daniel F. Mazo, Liliana S.C. Mendes, Claudia A.P. Ivantes, Valéria Faborges, Fabio H.L. Pace, Mario G. Pessoa, Izabelle V. Signorelli, Gabriela P. Coral, Paulo L. Bittencourt, Cynthia Levy, Cláudia A. Couto, Members of the Brazilian Cholestasis Study Group Consortium
Published 2021-09-01